Remisyonda Hodgkin Lenfoma Tanılı Bir CMV Enteriti Olgusu

CMV enterokoliti özellikle immunsupresif hastalarda görülen nadir bir hastalıktır. CMV enfeksiyonları normal immuniteli kişilerde asemptomatik veya nonspesifik semptomlarla seyreder. Ama immunsuprese kişilerde önemli morbidite ve mortaliteden sorumlu olabilir (3). CMV enterokoliti genelde ileumda ve sağ kolonda ortaya çıkar. Kolonoskoide multiple mukozal ülserler görülür. Bu makalede Remisyonda Hodgkin Lenfoma tanılı bir CMV enteriti olgusu sunuldu.

Abstract

CMV enterocolitis is a rare disease, especially seen in immunosuppressive patients. CMV infections are asymptomatic or present with nonspecific symptoms in people with normal immunity. But it may be responsible for significant morbidity and mortality in immunocompromised persons. CMV enterocolitis usually occurs in the ileum and right colon. Multıpl mucosal ulcers seen in colonoscopy. In this article a CMV enteritis case in diagnosed Hodgkin's lymphoma in remission was presented. 

Anahtar kelimeler

Sitomegalovirüs Enterokolit Hodgkin Lenfoma cytomegalovirus enterocolitis Hodgkin's Lymphoma

🔖

Bu Makaleye Atıf Yap

Çelik, M., Baran, A. İ., Acar, B. E., Kurt, Ö., Karahocagil, M. A. (2017). Remisyonda Hodgkin Lenfoma Tanılı Bir CMV Enteriti Olgusu. Harran Üniversitesi Tıp Fakültesi Dergisi, Cilt: 14 Sayı: 1, 71–74. https://ajindex.com/articles/1081588

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

Nomura K, Kamıtsuji Y, Kono E, Matsumoto Y, Yoshida N, Konishi H, et al. Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin’s lymphoma. Scandinavian Journal of Gastroenterology 2005; 40: 604-606
PageMJ, DreeseJC, Poritz LS, et al. Cytomegalovirus enteritis: A Highly lethal condition requiring early detection and ıntervention. Dis Colon Rectum 1998, Volume 41, Issue 5, p: 619-623
Shinozaki M, Masaki T, Muto T. Cytomegalic colitis after total colectomy in ulcerative colitis: report of a case. Dis Colon Rectum 1997;40:1124-1127
Mayoral JL, Loeffler CM, Fasola CG, Kramer MA, Orrom WJ, et al. Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg 1991;126:202-206
Shrestha BM, Parton D, Gray A, Shephard D, Griffith D, et al. Cytomegalovirus involving gastrointestinal tract in renal transplant recipients. Clin Transplantation 1996;10:170-175
Schulenburg A, Turetschek K, Wrba F, Vogelsang H, Greinix HT, Keil F, et al. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol 2004;83:101-106
Carpiuc I, Antoun S, Delabarthe A, Driss B, Vantelon JM, Griscelli F, et al. Segmental caecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome. Leuk Lymphoma 2002;43:1701-1703
Tezer H, Seçmeer G. Sitomegalovirüs (CMV) infeksiyonları. Hacettepe Tıp Dergisi 2007; 38:1-7
Gümüş HH, Yarkın F. Allojenik Hematopoetik Kök Hücre Transplant Alıcılarında Viral İnfeksiyonların Yönetimi. Arşiv Kaynak Tarama Dergisi 2014; 23(1):118-136
Perrottet N, Csajka C, Pascual M, Manuel O, Lamoth F, Meylan P, et al. Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir. Antimicrob Agents Chemother 2009 Jul; 53(7): 3017–3023.